Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grinspoon

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|February 21, 2009
Strategies to augment growth-hormone secretion in obesitySteven Grinspoon
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Physiologic effects of GHRH in patients with HIV lipodystrophy: a model of acquired visceral adipositySteven Grinspoon
Circulation|February 18, 2009
Diabetes mellitus, cardiovascular risk, and HIV diseaseSteven Grinspoon
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Androgen deficiency and HIV infectionSteven Grinspoon
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Mechanisms and strategies for insulin resistance in acquired immune deficiency syndromeSteven Grinspoon
Transactions of the American Clinical and Climatological Association|September 1, 2018
NOVEL MECHANISMS AND ANTI-INFLAMMATORY STRATEGIES TO REDUCE CARDIOVASCULAR RISK IN HUMAN IMMUNODEFICIENCY VIRUSSteven Grinspoon
The Journal of Infectious Diseases|May 12, 2007
Use of thiazolidinediones in HIV-infected patients: what have we learned?Steven Grinspoon
AIDS (London, England)|September 19, 2014
Epicardial adipose tissue and atherogenesis: EAT your heart outSteven Grinspoon
Annual Review of Medicine|January 30, 2004
HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversiesPolyxeni Koutkia, Steven Grinspoon
Circulation. Cardiovascular Imaging|July 5, 2017
Cardiovascular Disease Imaging in HIV: Novel Phenotypes and New Targets for Risk ReductionSteven Grinspoon, Udo Hoffmann
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Nature Clinical Practice. Endocrinology & Metabolism|February 21, 2009
Strategies to augment growth-hormone secretion in obesitySteven Grinspoon
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Physiologic effects of GHRH in patients with HIV lipodystrophy: a model of acquired visceral adipositySteven Grinspoon
Circulation|February 18, 2009
Diabetes mellitus, cardiovascular risk, and HIV diseaseSteven Grinspoon
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Androgen deficiency and HIV infectionSteven Grinspoon
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Mechanisms and strategies for insulin resistance in acquired immune deficiency syndromeSteven Grinspoon
Transactions of the American Clinical and Climatological Association|September 1, 2018
NOVEL MECHANISMS AND ANTI-INFLAMMATORY STRATEGIES TO REDUCE CARDIOVASCULAR RISK IN HUMAN IMMUNODEFICIENCY VIRUSSteven Grinspoon
The Journal of Infectious Diseases|May 12, 2007
Use of thiazolidinediones in HIV-infected patients: what have we learned?Steven Grinspoon
AIDS (London, England)|September 19, 2014
Epicardial adipose tissue and atherogenesis: EAT your heart outSteven Grinspoon
Annual Review of Medicine|January 30, 2004
HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversiesPolyxeni Koutkia, Steven Grinspoon
Circulation. Cardiovascular Imaging|July 5, 2017
Cardiovascular Disease Imaging in HIV: Novel Phenotypes and New Targets for Risk ReductionSteven Grinspoon, Udo Hoffmann
Pageof 11